Specifications Manual for Joint Commission National Quality Measures (v2020B)
Posted: 2/5/2020
Home » Reason for Not Administering Antithrombotic Therapy by End of Hospital Day 2

Release Notes:
Data Element
Version 2020B

Name:Reason for Not Administering Antithrombotic Therapy by End of Hospital Day 2
Collected For: ASR-IP-2, STK-5
Definition:Reason for not administering antithrombotic therapy by end of hospital day 2.
  • Other reasons documented by physician/APN/PA or pharmacist.
Question:Is there documentation by a physician/advanced practice nurse/physician assistant (physician/APN/PA) or pharmacist in the medical record of a reason for not administering antithrombotic therapy by end of hospital day 2?
Format:
Length:1
Type:Alphanumeric
Occurs:1
Allowable Values:

Y (Yes)     There is physician/APN/PA or pharmacist documentation of a reason for not administering antithrombotic therapy by end of hospital day 2.

N (No)     There is no physician/APN/PA or pharmacist documentation of a reason for not administering antithrombotic therapy by end of hospital day 2 or unable to determine from the medical record documentation.
Notes for Abstraction:
  • Documentation for allowable value “Yes” must be found within the timeframe of arrival to the end of hospital day 2. It is not necessary to review documentation outside of this timeframe to answer this data element.
  • To compute end of hospital day 2, count the arrival date as hospital day 1. If a reason for not administering antithrombotic therapy was documented by 11:59 P.M. of hospital day 2, select “Yes” for this data element.
  • Reasons for not administering antithrombotic therapy must be documented by a physician/APN/PA or pharmacist with one exception: Patient/family refusal of any form of antithrombotic therapy (e.g., “ASA refused,” “Patient refusing antithrombotic therapy”) may be documented by a nurse. However, it must be documented in the timeframe of arrival to the end of hospital day 2.
    Example:
    Patient arrived on 03/01/20XX. Nursing notes on 03/02/20XX indicates that patient refused antithrombotic therapy, select “Yes.”
  • If reasons are not mentioned in the context of antithrombotics, do not make inferences (e.g., do not assume that antithrombotic therapy was not administered because of a bleeding disorder unless documentation explicitly states so).
    • Reasons must be explicitly documented (e.g., “Hemorrhagic transformation – do not give aspirin,” “Active GI bleed – antithrombotic therapy contraindicated,” “H/O bleeding disorder – anticoagulation therapy contraindicated,” “Low platelet count - do not give antiplatelet medications,” “No ASA” [no reason given]).
    • Consider the terms "anticoagulant", "antiplatelet", and "blood thinners" synonymous with antithrombotic therapy. Physician/APN/PA or pharmacist documentation,(e.g., "no blood thinners", "no anticoagulant medications", "no antiplatelet medications"), select "Yes".
  • For patients receiving ticagrelor as antithrombotic therapy for acute coronary syndrome (ACS), NSTE-ACS treated with early invasive strategy and/or coronary stenting, or other indications, select “Yes” if it is administered on the day of or day after hospital arrival.
  • Prasugrel is inadvisable for patients with a history of transient ischemic attack or stroke. If prasugrel was administered on the day of or day after hospital arrival, select "Yes".
  • For patients with an order for ANY antithrombotic that was NOT administered without a documented reason or administered after day 2, select “No.”
    Example:
    Patient has documentation of an order for aspirin on day 2. No documentation that aspirin was administered by end of day 2. No documentation of a hold or discontinuation of the aspirin order or other documented reason, select “No.”
  • NPO is NOT a reason for not administering antithrombotic therapy without explicit documentation that no antithrombotic medication should be given. Another route of administration can be used.
  • An allergy or adverse reaction to one type of antithrombotic would NOT be a reason for not administering all antithrombotics. Another medication can be ordered.
  • For patients on warfarin therapy prior to hospital arrival and no order for warfarin on the day of or day after arrival due to “high INR,” select “Yes.”
Suggested Data Sources: ONLY PHYSICIAN/APN/PA OR PHARMACIST DOCUMENTATION OF A REASON FOR NOT ADMINISTERING ANTITHROMBOTIC THERAPY:
  • Consultation notes
  • Emergency room records
  • History and physical
  • Medication reconciliation form
  • Progress Notes

SUGGESTED DATA SOURCES FOR PATIENT/FAMILY REFUSAL (other than physician/APN/PA or pharmacist documentation of a reason for not administering antithrombotic therapy as noted above):
  • Medication Administration Record
  • Nurses notes

Excluded Data Sources:
Any documentation dated/timed prior to hospital arrival or after hospital day 2.
Additional Notes:
Guidelines for Abstraction:
Inclusion Exclusion
  • None
  • Refer to Appendix C, Table 8.2 for a comprehensive list of Antithrombotic Medications
  • Delay in stroke diagnosis

Reason for Not Administering Antithrombotic Therapy by End of Hospital Day 2
CPT® only copyright 2019 American Medical Association. All rights reserved.
Specifications Manual for Joint Commission National Quality Measures (v2020B)
Discharges 07-01-20 (3Q20) through 12-31-20 (4Q20)

LICENSE FOR USE OF CURRENT PROCEDURAL TERMINOLOGY, FOURTH EDITION (“CPT®”)

CPT® only copyright 2019 American Medical Association. All rights reserved. CPT® is a registered trademark of the American Medical Association.

You, your employees and agents are authorized to use CPT® only as contained in The Joint Commission performance measures solely for your own personal use in directly participating in healthcare programs administered by The Joint Commission. You acknowledge that the American Medical Association (“AMA”) holds all copyright, trademark and other rights in CPT®.

Any use not authorized herein is prohibited, including by way of illustration and not by way of limitation, making copies of CPT® for resale and/or license, transferring copies of CPT® to any party not bound by this Agreement, creating any modified or derivative work of CPT®, or making any commercial use of CPT®. License to use CPT® for any use not authorized herein must be obtained through the American Medical Association, Intellectual Property Services, AMA Plaza, 330 North Wabash Avenue, Suite 39300, Chicago, Illinois 60611-5885. Applications are available at the American Medical Association Web site, www.ama- assn.org/go/cpt.

U.S. Government Rights This product includes CPT® which is commercial technical data, which was developed exclusively at private expense by the American Medical Association, 330 North Wabash Avenue, Chicago, Illinois 60611. The American Medical Association does not agree to license CPT® to the Federal Government based on the license in FAR 52.227-14 (Data Rights - General) and DFARS 252.227-7015 (Technical Data - Commercial Items) or any other license provision. The American Medical Association reserves all rights to approve any license with any Federal agency.

Disclaimer of Warranties and Liabilities. CPT® is provided “as is” without warranty of any kind, either expressed or implied, including but not limited to the implied warranties of merchantability and fitness for a particular purpose. Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT®, and the (AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The responsibility for the content of this product is with The Joint Commission, and no endorsement by the AMA is intended or implied. The AMA disclaims responsibility for any consequences or liability attributable to or related to any use, non-use, or interpretation of information contained or not contained in this product.

This Agreement will terminate upon notice if you violate its terms. The AMA is a third party beneficiary to this Agreement.

Should the foregoing terms and conditions be acceptable to you, please indicate your agreement and acceptance by clicking below on the button labeled “accept”.

^